• Developed and executed a Federal market access strategy for VBI Vaccine Inc, resulting in formulary approvals for key agencies like VA, DoD, FBoP, I.H.S. H.L.S. and CDC.• Coordinated the Federal contracting platform SAM-(CAGE) FSS process to ensure efficient pricing structure across all Federal Agencies.• Established VBI Vaccine Inc in the Federal space, creating a clear strategic and tactical pull through platform for success.

• Delivering a trusted, predictable, proven platform that delivers a clear and concise process. The process starts with an in-depth analysis to validate and quantify the revenue opportunity, accurately project timelines and optimize contracting options. The next phases deliver a concise strategic/tactical path, execution and ultimately transition the entire operational platform back to the organization. • Operational Focus; Pharmaceutical, Biologic's, Specialty Pharma Manufacturers, Medical Device, Disposable Medical Equipment, Capital Equipment,Software• 2010-Present- Managing Director Federal Medical Access Consulting. • 2017 -2019-Created / executed strategic/ tactical platform for Pharma/Capital Equip– Pain Mgmt. • 2016 -2017-Developed/implemented strategic/tactical platforms for 2 DME organizations (Diagnostic) • 2014- 2016-Developed and executed a successful VA push/ pull- through for 2 pharma (Atypicals) -• 2013-2014-National Association of Chronic Disease Directors (NACDD ), CDC & CMS transforming the NDPP (National Diabetes Prevention Program) • 2012-2013-Created / executed a National VA/DoD Strategic/Tactical Med Dev (Point of Care) • 2010-2012-Developed a Strategic/ Tactical VHA platform- Behavioral Health Coaching Visit the website: https://www.fedmedaccess.com/

Senior Federal Account Director 2004-2010Federal Account Director 2002-2004 Regional Account Dir II (Commercial) 1999-2002Regional Account Dir. I (Commercial) 1997-1998Regional Account Mgr (Commercial) 1994-1996•FBOP (Federal Bureau of Prisons)-Delivered formulary inclusion of atypical resulting in immediate $2.1 MM product acquisition reflecting $14.5M annually. •VA dyslipidemia contract negotiations delivering a successful statin BPA. Growth from 1.0% to 13.9% nationally (+immediate 2.8 MM -annually $18.0 MM) •Incorporating the VA / FBOP with VBID (Value Based Insurance Design), outcome based efficiencies•Created an integrated approach with the Blue Cross leadership specific to aligning DoD/ TriCare pull through across all teams